These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11035998)

  • 1. Statistical issues in toxicokinetic modeling: a bayesian perspective.
    Bernillon P; Bois FY
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():883-93. PubMed ID: 11035998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data.
    Cooper AB; Aggarwal M; Bartels MJ; Morriss A; Terry C; Lord GA; Gant TW
    Regul Toxicol Pharmacol; 2019 Mar; 102():1-12. PubMed ID: 30543831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.
    Hack CE
    Toxicology; 2006 Apr; 221(2-3):241-8. PubMed ID: 16466842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bayesian population approach to physiological toxicokinetic-toxicodynamic models--an example using the MCSim software.
    Jonsson F; Johanson G
    Toxicol Lett; 2003 Feb; 138(1-2):143-50. PubMed ID: 12559698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors.
    Pelekis M; Nicolich MJ; Gauthier JS
    Risk Anal; 2003 Dec; 23(6):1239-55. PubMed ID: 14641898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.
    Schmidt PJ; Pintar KD; Fazil AM; Topp E
    Risk Anal; 2013 Sep; 33(9):1677-93. PubMed ID: 23311599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction uncertainty assessment of chromatography models using Bayesian inference.
    Briskot T; Stückler F; Wittkopp F; Williams C; Yang J; Konrad S; Doninger K; Griesbach J; Bennecke M; Hepbildikler S; Hubbuch J
    J Chromatogr A; 2019 Feb; 1587():101-110. PubMed ID: 30579636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian toxicokinetic modeling of cadmium exposure in Chinese population.
    Qing Y; Yang J; Zhang Q; Zhu Y; Ruiz P; Wu M; Zhao G; Zhao Q; Liu H; Cai H; Qin L; Zheng W; He G
    J Hazard Mater; 2021 Jul; 413():125465. PubMed ID: 33930974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations to address uncertainties in environmental risk assessment using toxicokinetic-toxicodynamic models.
    Baudrot V; Charles S
    Sci Rep; 2019 Aug; 9(1):11432. PubMed ID: 31391484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach.
    Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2002 Feb; 179(1):35-49. PubMed ID: 11884235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian analysis of physiologically based toxicokinetic (PBTK) modeling for pentachlorophenol exposure in pregnant women.
    Wu C; Tan Y; Wei X; Li X; Sun S; Lyu B; Shen Z; Wei X; Xiao S; Ruan Y; Yu J; He G; Zheng W; Li J
    Toxicol In Vitro; 2024 Aug; 99():105853. PubMed ID: 38806067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of PBPK models for risk characterization.
    Bois FY
    Ann N Y Acad Sci; 1999; 895():317-37. PubMed ID: 10676425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating parameter uncertainty into Quantitative Microbial Risk Assessment (QMRA).
    Donald M; Mengersen K; Toze S; Sidhu JP; Cook A
    J Water Health; 2011 Mar; 9(1):10-26. PubMed ID: 21301111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.
    Shao K; Gift JS
    Risk Anal; 2014 Jan; 34(1):101-20. PubMed ID: 23758102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
    Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian Analysis of a Lipid-Based Physiologically Based Toxicokinetic Model for a Mixture of PCBs in Rats.
    Sasso AF; Georgopoulos PG; Isukapalli SS; Krishnan K
    J Toxicol; 2012; 2012():895391. PubMed ID: 22315591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian uncertainty quantification and propagation in molecular dynamics simulations: a high performance computing framework.
    Angelikopoulos P; Papadimitriou C; Koumoutsakos P
    J Chem Phys; 2012 Oct; 137(14):144103. PubMed ID: 23061835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.